<unk>  is an androgen antagonist that is FDA approved for the treatment of carcinoma of prostate, stage B2, C or D2, in combination with an LHRH agonist. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include rash, hot sweats, diarrhea, nausea.
Flutamide
Bicalutamide
Carbutamide
Nilutamide
Apalutamide
Enzalutamide
Tamoxifen
Anastrozole